HSBC Holdings
ORIC icon

HSBC Holdings’s Oric Pharmaceuticals ORIC Stock Holding History

HSBC Holdings’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,983
Closed -$102K – 3188
2025
Q1 		$102K Buy
+17,983
New +$157K ﹤0.01% 2803
2023
Q1 		– Sell
-55,000
Closed -$296K – 2945
2022
Q4 		$296K Sell
55,000
-5,000
-8% -$16.9K ﹤0.01% 2564
2022
Q3 		$192K Buy
60,000
+25,000
+71% +$100K ﹤0.01% 2642
2022
Q2 		$158K Buy
+35,000
New +$140K ﹤0.01% 2938

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

HSBC Holdings's ORIC Position: Q2 2025 in Review

HSBC Holdings sold out of Oric Pharmaceuticals (ORIC) in Q2 2025, closing a stake of 17,983 shares — an estimated $102K sold.

HSBC Holdings first reported a position in ORIC in Q2 2022 and held it in 4 quarters. The position peaked at $296K in Q4 2022. 142 funds tracked by Wall St. Rank hold ORIC as of Q2 2025.

  • HSBC Holdings reported no remaining Oric Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 17,983 Oric Pharmaceuticals shares in Q2 2025, an estimated $102K.
  • HSBC Holdings first reported a position in Oric Pharmaceuticals in Q2 2022 and held it in 4 quarters.
  • HSBC Holdings's Oric Pharmaceuticals position peaked at $296K in Q4 2022.
  • 142 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.